In research published in Nature Communications, Thomas Burris, Ph.D., chair of pharmacological and physiological science at Saint Louis University, reports intriguing findings about a small molecule that directs the activity of key "clock proteins," offering the potential to manage circadian rhythm and treat problems that are associated with its dysfunction, like sleep and anxiety disorders.
from The Medical News http://ift.tt/1xLd4w4
from The Medical News http://ift.tt/1xLd4w4
No comments:
Post a Comment